tiprankstipranks
Trending News
More News >
Nautilus Biotechnolgy (NAUT)
NASDAQ:NAUT
US Market

Compare Nautilus Biotechnolgy (NAUT) vs. Competitors

Compare
167 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Nautilus Biotechnolgy
$1.98
$250.08M
-3.97
16.17%
2 Buy
0 Hold
0 Sell
Moderate Buy
VistaGen Therapeutics
$0.73
$28.77M
-0.46
-74.20%
0 Buy
5 Hold
0 Sell
Hold
Adverum Biotechnologies
-7.04%
Kalaris Therapeutics
$9.26
$154.91M
-1.25
-13.14%
3 Buy
1 Hold
0 Sell
Strong Buy
Seer
$1.84
$102.65M
-1.35
-19.47%
1 Buy
0 Hold
0 Sell
Moderate Buy
Acumen Pharmaceuticals
$2.11
$127.81M
-0.96
12.36%
5 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
NAUT
Nautilus Biotechnolgy
1.94
0.27
16.17%
VTGN
VistaGen Therapeutics
0.66
-2.15
-76.41%
ADVM
Adverum Biotechnologies
4.36
-0.33
-7.04%
KLRS
Kalaris Therapeutics
9.13
-1.17
-11.37%
SEER
Seer
1.82
-0.45
-19.82%
ABOS
Acumen Pharmaceuticals
2.00
0.25
14.29%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts